Jane Gross

Jane Gross

Director/Board Member at ATYR PHARMA, INC.

Net worth: 2 954 $ as of 2026-09-29

69 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Jane A. Gross is an Independent Director at BriaCell Therapeutics Corp., an Independent Director at aTyr Pharma, Inc. and an Independent Director at BriaPro Therapeutics Corp.
She is on the Board of Directors at BriaCell Therapeutics Corp., aTyr Pharma, Inc., Life Science Washington and BriaPro Therapeutics Corp.
Dr. Gross was previously employed as a Chief Scientific Officer & Senior Vice President by Aptevo Therapeutics, Inc., a VP-Applied Research & Non-Clinical Development by Emergent BioSolutions, Inc., and a Vice President-Immunology Research by ZymoGenetics, Inc. She received her doctorate degree from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-26 9,750 ( 0.01% ) 2 954 $ 2026-09-29
-.--%
2026-03-31 0 ( -.--% ) - $ 2026-03-30
2026-07-06 0 ( -.--% ) - $ 2026-09-29

Jane Gross active positions

CompaniesPositionStart
ATYR PHARMA, INC. Director/Board Member 2019-06-27
BRIACELL THERAPEUTICS CORP. Director/Board Member 2022-01-17
Director/Board Member -
Director/Board Member -

Former positions of Jane Gross

CompaniesPositionEnd
APTEVO THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 2021-09-13
EMERGENT BIOSOLUTIONS INC. Corporate Officer/Principal 2016-07-31
Corporate Officer/Principal 2010-05-31
See the detail of Jane Gross's experience

Education of Jane Gross

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology